Indian drugmaker Aurobindo Pharma plans to scale up production of Penicillin-G to more than 10,000 metric tonnes annually within the next 12 months. The Hyderabad-based pharmaceutical company ...

Eugia III resolution (in the backdrop of fresh observations) and the launch momentum across geographies would be key determinants, say analysts.

The newly formed entity will operate in the pharmaceuticals sector and has been set up to expand the company's contract manufacturing and other pharmaceutical manufacturing operations ...

Aurobindo Pharma shares swung sharply on Wednesday after the company clarified in a filing that talk of a potential $5–5.5 billion buyout of Prague-based Zentiva is “premature” and no binding ...

Feb 6 (Reuters) - Indian drugmaker Aurobindo Pharma (ARBN.NS), opens new tab reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic ...

Aurobindo Pharma plans to increase Penicillin-G production to over 10,000 metric tonnes annually in the next 12 months. The Hyderabad-based company's strategies aim to improve profitability through ...

MUMBAI, Feb 10 (Reuters) - Indian drugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald ...